# SK Plasma wins Singapore national blood product tender for 6-year exclusive supply

SK Plasma, a subsidiary of SK Discovery, won a national tender from the Singapore government to exclusively supply blood products (albumin and human immunoglobulin) for 6 years starting 2023. The contract is valued at approximately $23 million.

- Type: Contract
- Announced: 2021-11-03
- Where: Singapore, Singapore
- Value: $23.0M
- Status: announced
- Products: albumin, human immunoglobulin
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [SK Plasma](https://endata.com/companies/58610.md) (supplier)
- [Government of Singapore](https://endata.com/companies/58611.md) (customer)

## Sources

- [mk.co.kr](https://www.mk.co.kr/news/it/10083621), 2021-11-02: "이번 성과는 품질에 대해 까다로운 눈높이를 지닌 싱가포르 당국에서 국내 기업의 기술력과 관리·생산 능력을 인정받은 첫 사례"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.